These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 3110269)

  • 21. Involvement of Lyt-2 and L3T4 in activation of hapten-specific Lyt-2+ L3T4+ T-cell clones.
    Fazekas de St Groth B; Gallagher PF; Miller JF
    Proc Natl Acad Sci U S A; 1986 Apr; 83(8):2594-8. PubMed ID: 3085100
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blocking of CTL-mediated killing by monoclonal antibodies to LFA-1 and Lyt-2, 3. II. Evidence that trypsin pretreatment of target cells removes a non-H-2 molecule important in killing.
    Gromkowski SH; Heagy W; Martz E
    J Immunol; 1985 Jan; 134(1):70-7. PubMed ID: 3880579
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence implicating L3T4 in class II MHC antigen reactivity; monoclonal antibody GK1.5 (anti-L3T4a) blocks class II MHC antigen-specific proliferation, release of lymphokines, and binding by cloned murine helper T lymphocyte lines.
    Wilde DB; Marrack P; Kappler J; Dialynas DP; Fitch FW
    J Immunol; 1983 Nov; 131(5):2178-83. PubMed ID: 6195255
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Specificity, phenotype, and precursor frequency of primary cytolytic T lymphocytes specific for class II major histocompatibility antigens.
    Golding H; Singer A
    J Immunol; 1985 Sep; 135(3):1610-5. PubMed ID: 3874902
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Requirements for the generation of a Lyt-2+ T-cell proliferative response to a syngeneic tumor in the absence of L3T4+ T-cells.
    Kern DE; Klarnet JP; Cheever MA; Greenberg PD
    Cancer Res; 1990 Oct; 50(19):6256-63. PubMed ID: 2144789
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The influence of valence on the functional activities of monoclonal anti-L3T4 antibodies. Discrimination of signaling from other effects.
    Haque S; Saizawa K; Rojo J; Janeway CA
    J Immunol; 1987 Nov; 139(10):3207-12. PubMed ID: 2960730
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Graft-vs-host reaction limited to a class II MHC difference results in a selective deficiency in L3T4+ but not in Lyt-2+ T helper cell function.
    Moser M; Mizuochi T; Sharrow SO; Singer A; Shearer GM
    J Immunol; 1987 Mar; 138(5):1355-62. PubMed ID: 2949013
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Specific lymphocyte-target cell conjugate formation between tumor-specific helper T-cell hybridomas and IA-bearing RCS tumors and IE-bearing allogeneic cells. I. Role of Ia and both L3T4 and LFA-1 antigens in recognition/binding.
    Ohnishi K; Bonavida B
    J Immunol; 1986 Dec; 137(11):3681-8. PubMed ID: 2946766
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of accessory cell and T cell surface antigens on mitogen-induced IL 2 receptor expression.
    Malek TR; Chan C; Glimcher LH; Germain RN; Shevach EM
    J Immunol; 1985 Sep; 135(3):1826-33. PubMed ID: 3926885
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surface markers of T cells causing lethal graft-vs-host disease to class I vs class II H-2 differences.
    Korngold R; Sprent J
    J Immunol; 1985 Nov; 135(5):3004-10. PubMed ID: 3876371
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction and blocking of cytolysis in CD2+, CD3- NK and CD2+, CD3+ cytotoxic T lymphocytes via CD2 50 KD sheep erythrocyte receptor.
    Bolhuis RL; Roozemond RC; van de Griend RJ
    J Immunol; 1986 Jun; 136(11):3939-44. PubMed ID: 3084649
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of the L3T4-antigen in T cell activation. II. Inhibition of T cell activation by monoclonal anti-L3T4 antibodies in the absence of accessory cells.
    Wassmer P; Chan C; Lögdberg L; Shevach EM
    J Immunol; 1985 Oct; 135(4):2237-42. PubMed ID: 3897371
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A role of L3T4+ antigen in the Con A response of regenerating splenic L3T4+ T cells after Cy treatment.
    Ikezawa Z; Sato M; Aoki I
    Immunology; 1987 Mar; 60(3):375-82. PubMed ID: 3106196
    [TBL] [Abstract][Full Text] [Related]  

  • 34. GVHR elicited by products of class I or class II loci of the MHC: analysis of the response of mouse T lymphocytes to products of class I and class II loci of the MHC in correlation with GVHR-induced mortality, medullary aplasia, and enteropathy.
    Piguet PF
    J Immunol; 1985 Sep; 135(3):1637-43. PubMed ID: 2410497
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation requirements of cloned inducer T cells. I. Differential inhibition by anti-L3T4 or anti-I-A is determined by the accessory cell population.
    DeKruyff R; Clayberger C; Cantor H; Dorf ME
    J Immunol; 1985 Oct; 135(4):2243-8. PubMed ID: 3897372
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cloned Listeria monocytogenes specific non-MHC-restricted Lyt-2+ T cells with cytolytic and protective activity.
    Kaufmann SH; Rodewald HR; Hug E; De Libero G
    J Immunol; 1988 May; 140(9):3173-9. PubMed ID: 3129513
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Search for class II major histocompatibility complex molecular involvement in the response of Lyt-2+ cytotoxic T lymphocyte precursors to alloantigen.
    Romani L; Mage MG
    Eur J Immunol; 1985 Nov; 15(11):1125-30. PubMed ID: 2933265
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of bispecific heteroconjugated antibodies (anti-T cell antigen receptor x anti-MHC class II) to study activation of T cells with a full length or truncated antigen receptor zeta-chain.
    Wu S; Yang Y; Sadegh-Nasseri S; Ashwell JD
    J Immunol; 1993 Mar; 150(6):2211-21. PubMed ID: 8450208
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of L3T4+ and Lyt-2+ donor cells in graft-versus-host immune deficiency induced across a class I, class II, or whole H-2 difference.
    Moser M; Sharrow SO; Shearer GM
    J Immunol; 1988 Apr; 140(8):2600-8. PubMed ID: 3258615
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD4-Ia interactions can occur in the absence of T-cell receptor/antigen-Ia recognition.
    Andris F; Leo O; Van Mechelen M; Urbain J; Slaoui M
    Immunology; 1989 Sep; 68(1):1-6. PubMed ID: 2530152
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.